Compare Immunovant Inc. Common Stock (IMVT) vs Roblox Corp (RBLX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Immunovant Inc. Common Stock vs Roblox Corp — how do they compare? Immunovant Inc. Common Stock trades at $30.25 (market cap $6.25B), while Roblox Corp trades at $46.04 (market cap $32.52B). The key difference: Roblox Corp is far larger — about 5.2× Immunovant Inc. Common Stock's market cap, and Immunovant Inc. Common Stock is trading nearer its 52-week high, Roblox Corp nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Immunovant Inc. Common Stock for 0 Days and Roblox Corp for 93 Days on average.
| IMVT | RBLX | |
|---|---|---|
Market Cap | $6.25B | $32.52B |
Volume | 1,755,411 | 14,552,045 |
Sector | Health | Technology |
52-Week High | $44.96 | $138.56 |
52-Week Low | $17.03 | $35.54 |
Typical Hold Time | 0 Days | 93 Days |
Enterprise Value | $5.35B | $31.34B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Roblox (RBLX) trades at $46.41, up 1.87% with bullish technical indicators and strong support at $45. The company shows impressive revenue growth from $2.2B in 2022 to $4.89B in 2025, though it remains unprofitable with a -17.61% net margin. Recent earnings have consistently beaten expectations, and operating cash flow improved significantly to $1.8B in 2025.
While analyst sentiment is mixed with 42% buy ratings, the consensus price target of $50.85 suggests 9.6% upside potential. Key risks include persistent losses, high P/B ratio of 213.94, and recent Jefferies downgrade citing bookings concerns. The stock's trajectory depends on continued user growth and path to profitability.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Immunovant Inc. Common Stock
Immunovant is a clinical-stage immunology company developing therapies for autoimmune diseases. Its pipeline includes anti-FcRn antibody candidates designed for subcutaneous administration.
Read more on IMVT →About Roblox Corp
Roblox operates an online video game platform that lets young gamers create, develop, and monetize games (or experiences) for other players. The firm effectively offers its developers a hybrid of a game engine, publishing platform, online hosting and services, marketplace with payment processing, and social network. The platform is a closed garden that Roblox controls, earning revenue in multiple places while benefiting from outsourced game development. Unlike traditional video game publishers, Roblox is more focused on the creation of new tools and monetization techniques for its developers then creating new games or franchises. Roblox is increasingly focused on creating a metaverse that moves beyond games toward experiences like concerts, education, and even business management.
Read more on RBLX →
